Category Archives for: NYSE:PBE

Quick Investor Guide To Biotech ETFs [iShares NASDAQ Biotechnology Index (ETF), SPDR S&P Biotech (ETF)]

biotechMergers and acquisitions (M&As) continue to play a major role in the biotech sector and are not showing any signs of slowing down. Biotech companies have always attracted a lot of interest especially from their pharma counterparts
NASDAQ:IBB October 3, 2014 3:15pm

How Will Biotech ETFs Finish Out The Year? [Biogen Idec Inc, Celgene Corporation, Amgen, Inc., Merck & Co., Inc.]

biotechThe Biotechnology ETF world has been on a roller coaster ride this year. After peaking at the beginning of March, the space saw a huge sell-off until the middle of April, after which it has seen some recovery in the past two months.
NASDAQ:BIB June 18, 2014 4:16pm

Biotech ETFs To Buy On The Dip [SPDR S&P Biotech (ETF), Gilead Sciences, Inc., iShares NASDAQ Biotechnology Index (ETF)]

biotechnologyThe high flying, and top performing, sector of 2013 – biotech – delivered impressive gains last year, on the back of increasing mergers and acquisition activities, expansion into emerging markets,
NASDAQ:IBB March 31, 2014 10:22pm

Quick Investor Guide To Surging Biotech ETFs [iShares NASDAQ Biotechnology Index (ETF), SPDR S&P Biotech (ETF)]

biotechnologyThe healthcare industry, especially its biotechnology corner, gave an astounding performance last year with the S&P biotechnology select industry index returning about 70%. The performance has been exciting so far this year too, as evident from 15% return
NYSE:BBH February 11, 2014 5:17pm

Time To Take Advantage of the Slaughter in Biotech [NYSE ARCA BIOTECH INDEX, Amgen, Inc.]

biotechnology: At the J.P. Morgan Healthcare Conference in San Francisco three weeks ago, it was all rainbows and unicorns when it came to the biotech sector. At that point, the sector had climbed 50% over the previous year and
NASDAQ:BIB January 31, 2014 2:14pm

Obama’s Second Term Has Been Great For These ETFs [First Trust NASDAQ Clean Edge US (ETF), PowerShares Dynamic Biotech &Genome(ETF)]

obamaAccording to some myths, the first year of a presidency is generally the worst for the stock market but President Obama's first year of his second term proved to be an exception.
NASDAQ:QCLN January 25, 2014 12:12pm

3 ETFs That Should Crush The Market In 2014 [First Trust NASDAQ Clean Edge US (ETF), PowerShares Dynamic Biotech &Genome(ETF)]

etfs2013 was obviously a great year for the markets, as a better economic outlook propelled stocks sharply higher. Pretty much every sector was in the green for the time frame, leading to high hopes for the New Year.
NASDAQ:QCLN January 20, 2014 10:22pm

Are Biotech ETFs Back On Track?

biotechnologyThe healthcare industry, especially its biotechnology corner, has been a great performer so far this year as evident from an impressive 43.64% gain in S&P biotechnology select industry index in the last one year (as of November 25, 2013). The credit for this bull run
NASDAQ:IBB December 3, 2013 6:18pm

How To Play The Bullish Trend In Healthcare With ETFs

healthcare-etfsWhile there have been a series of volatility-inducing events in the U.S. starting from the Fed’s ‘Taper Talk’ and then the tussle between the Republicans and the Democrats, investors have still remained relatively bullish and have put capital
NYSE:BBH November 1, 2013 1:13pm

Can The Run Continue For Biotech ETFs?

biotechnologyBiotechnology firms are among the fasting growing companies in the health care world. With the U.S. market soaring, a high growth and high beta sector like biotech is performing remarkably well, clearly outpacing the overall market
NASDAQ:IBB October 23, 2013 6:18pm

Top Ranked PowerShares Dynamic Biotech/Genome ETF In Focus

in focus spotlight One of the sectors which has remained in the limelight in 2013 is healthcare, and biotechnology in particular. This space has led the broad market for most of the first half of 2013, and has been continuing its incredible run into the second
NYSE:PBE October 8, 2013 3:15pm

3 Healthcare ETFs To Play For The Remainder Of 2013

healthcare1The healthcare space has led the broad market for most of the first half of 2013 and continues its incredible run into the second half as well. In fact, the SPDR Health Care Select Sector Fund (XLV) is up nearly 24.9% in the year-to-date timeframe
NASDAQ:PSCH August 28, 2013 4:16pm

Why The Future Is Increasingly Bright For Biotech ETFs

biotechnologyStocks were broadly higher to start the second half of the year as markets rose on strong economic data in a few key segments of the economy. While many market sectors participated in the rally, one corner of the market saw especially
NASDAQ:IBB July 3, 2013 11:11am

5 ETFs To Tap The Biotechnology Sector

biotechnologyWith ever-increasing health care spending and insatiable demand for new drugs, the biotechnology sector looks poised for good growth going forward. Furthermore, the U.S. biotech sector represents an attractive investment opportunity thanks
NASDAQ:IBB May 28, 2013 2:14pm

Recommended for You

Partner Center


Explore More from ETFDailyNews.com

Free Daily Newsletter

Get daily ETF insights from our market experts. Never miss another important market development again!

ETFDailyNews.com respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary POWR Ratings system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories